Login / Signup

Outcomes of patients with HER2-negative metastatic breast cancer after platinum- and non-platinum-based first-line chemotherapy among patients with and without pathogenic germline BRCA1/2 mutations.

William JacotAmélie LusqueCécile VicierAudrey MailliezThibault de La Motte RougeLuc CabelChristelle LevyAnne PatsourisIsabelle DesmoulinsLionel UwerJean-Christophe TheryMathieu RobainOlivier CaronOlivier TredanThomas FilleronJean-Sébastien FrenelSuzette Delaloge
Published in: British journal of cancer (2022)
NCT03275311.
Keyphrases
  • metastatic breast cancer
  • locally advanced
  • dna repair
  • type diabetes
  • metabolic syndrome
  • dna damage
  • insulin resistance
  • glycemic control